Tolerability and pharmacokinetic analyses of combination therapy with darolutamide (DARO), androgen-deprivation therapy (ADT), and docetaxel (DOC) in patients with metastatic hormone sensitive prostate cancer (mHSPC) from ARASENS

Autor:	B. Tombal, M.R. Smith, M. Hussain, F. Saad, K. Fizazi, C.N. Sternberg, E.D. Crawford, S. Kapur, W. Zhang, B. Ploeger, R. Li, I. Kuss, C. Zieschang, S. Wittemer-Rump, A. Rezazadeh Kalebasty
Rok vydání:	2023
Předmět:	Urology
Zdroj:	European Urology. 83:S1709-S1710
ISSN:	0302-2838
DOI:	10.1016/s0302-2838(23)01222-8
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::46a0174b13708aa3848929c77f5d7da2 https://doi.org/10.1016/s0302-2838(23)01222-8 Zobrazit plný text záznamu Full Text from ScienceDirect